NewsBenzingaCelldex Drops Atopic Dermatitis Study Following Weak Phase 2 Pruritus Data Celldex Drops Atopic Dermatitis Study Following Weak Phase 2 Pruritus Data Benzinga 2026.11.20 14:33 (GMT+0) Open on Benzinga Other news Global Stocks Retreat on Unwind of the AI Trade Nvidia's Market Cap Overtaken by Google, Shrinking to $3.4 Trillion What Are Wall Street Analysts' Target Price for W. R. Berkley Stock? Are Wall Street Analysts Bullish on lululemon athletica Stock? SpaceX shares fall 5.1%, hitting two-week low Nvidia stock falls 4.7%, hitting lowest level since June 2025